23 September, 2024 | News
Accurate identification of disease-causing genetic alterations is crucial for refining the diagnosis and treatment of blood cancers. The broad gene panel for myeloid malignancies, a subset of blood cancers, developed by Genomic Medicine Sweden in collaboration with...